XML 53 R43.htm IDEA: XBRL DOCUMENT v3.25.0.1
Stockholders' Equity - Summary of Stock Option Activity (Detail) - $ / shares
1 Months Ended 12 Months Ended
Nov. 30, 2024
Dec. 31, 2024
Dec. 31, 2023
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]      
Options, Outstanding ending balance   126,015  
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price [Roll Forward]      
Weighted Average Exercise Price, Outstanding ending balance $ 164.47    
Restated Equity Incentive Plan 2013 [Member]      
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]      
Options, Outstanding beginning balance   51,983  
Options, Granted   126,015  
Options, Expired   (248)  
Options, Forfeited or cancelled   (51,735)  
Options, Outstanding ending balance   126,015 51,983
Options, Vested and expected to vest at December 31, 2024   126,015  
Options, Exercisable at December 31, 2024   5,442  
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price [Roll Forward]      
Weighted Average Exercise Price, Outstanding beginning balance   $ 170.9  
Weighted Average Exercise Price, Granted   5.29  
Weighted Average Exercise Price, Expired   1,036.8  
Weighted Average Exercise Price, Forfeited or cancelled   166.75  
Weighted Average Exercise Price, Outstanding ending balance   5.29 $ 170.9
Weighted Average Exercise Price, Vested and expected to vest at December 31, 2024   5.29  
Weighted Average Exercise Price, Exercisable at December 31, 2024   $ 5.27  
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Remaining Contractual Term [Abstract]      
Weighted Average Remaining Contractual Term (Years), Outstanding   7 years 2 months 12 days 7 years 1 month 6 days
Weighted Average Remaining Contractual Term (Years), Vested and expected to vest at December 31, 2024   7 years 2 months 12 days  
Weighted Average Remaining Contractual Term (Years), Exercisable at December 31, 2024   7 years 6 months